Please Wait...

DKK-1 // Dickkopf Related Protein-1

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Dickkopf family members are involved in the modulation of Wnt signaling. DKK1, the first member of this family (which comprises at least 4 cystein-rich protein), is an inhibitor of Wnt signaling. DKK1 has been found to not only promote bone resorption in a mouse model of arthritis but also to block bone formation and repair of diseased joint (Diarra et al., 2007). DKK1 appeared as a central player in bone homeostasis with implication in bone development and maintenance of bone mass as well as in formation of bone metastases (Pinzone et al., 2009).

Bioclinica Lab employs two manual immunoassays for the measurement of DKK1; one is dedicated to measurements in plasma EDTA and the second to measurements in serum.


Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (5 minutes ago)
@CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of…
bioclinica (10 minutes ago)
RT @CDISC: Special thanks to CDISC Member @bioclinica for hosting CDISC Public Training in Audubon, PA 2-6 Apr 2018. Register today. https:…
bioclinica (26 minutes ago)
Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil…
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace…
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c…
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen